OLFM4 and chronic myelogenous leukemia, BCR-ABL1 positive: We validated this hypothesis by demonstrating the successful application of the iPSC-based platform to discover OLFM4 as a novel primitive leukemia cell survival factor in patients in the chronic phase of CML.